Business Wire

NetApp and Cisco Accelerate and Secure AI Innovation

3.6.2026 14:00:00 CEST | Business Wire | Press Release

Share

NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, and Cisco (NASDAQ: CSCO) today announced that they have collaborated to offer new validated solutions for secure, scalable, and simplified AI. Expanding the proven success of FlexPod, the new solutions provide a simple, reliable path for enterprises to address the specific challenges AI workloads place on compute, network, and storage infrastructure.

“As IT teams are tasked with delivering reliable, consistent performance across environments, AI workloads are placing increasing demands on their data infrastructure,” said Dallas Olson, Chief Commercial Officer at NetApp. “NetApp and Cisco’s longstanding partnership on FlexPod has already proven effective, saving customers up to 20 percent of their time in infrastructure management and maintenance. Now, we are applying our combined expertise to modern challenges to accelerate AI adoption while reducing risk with built-in security.”

NetApp and Cisco are expanding FlexPod to support AI adoption across different organizational sizes and maturity levels, using pre-tested, validated architectures and enterprise-grade data management as a consistent foundation. These solutions support use cases such as:

  • Enterprise AI Deployments: Enterprises can simply and quickly deploy high-performance infrastructure for AI use cases including retrieval-augmented generation (RAG) and semantic search using this validated architecture. FlexPod reduces integration complexity while allowing AI capabilities to run directly where the data resides, with built-in, end-to-end security. This architecture includes disaggregated storage for independent scaling of performance and capacity with NetApp AFX; future functionality of data discovery, preparation and governance capabilities from NetApp AI Data Engine (AIDE) which integrates the NVIDIA AI Data Platform reference design; and distributed security and Zero Trust-aligned controls across the AI pipeline for AI-specific risks from Cisco Secure AI Factory with NVIDIA. Underpinning the Secure AI Factory, Cisco AI networking infrastructure with Nexus One transforms the network into a deterministic, high-performance fabric to maximize XPU utilization, reduce job completion times, and deliver predictable AI outcomes at scale. Targeting full-stack enterprise AI use cases, NetApp and Cisco have collaborated with NVIDIA to build FlexPod Solutions based on NVIDIA Enterprise Reference Architectures, enabling organizations to design, deploy, and scale high-performance AI factories.
  • AI Inferencing and RAG Workflows: To enable teams and departments to tap into the benefits of AI with their existing data, this simplified, pre-integrated solution is designed to lower the cost, complexity, and specialized skill requirements associated with deploying AI infrastructure.
  • Edge Computing: This solution enables enterprises to support AI inferencing, containerized, and virtualized workloads at the edge while maintaining low latency and operational consistency. By extending proven FlexPod architecture to remote and edge locations, customers benefit from faster time to value and reduced operational complexity compared to bespoke infrastructure or isolated IT stacks at each site. Combining Cisco Unified Edge with flexible NetApp storage options delivers a flexible, validated converged solution. Centralized fleet management, policy-based configuration, and automated orchestration enable repeatable deployments and simplified operations across highly distributed environments.

“As organizations move from AI experimentation to real‑world deployment, security can’t be an afterthought. It has to be built in from the start,” said Jeremy Foster, GM and SVP at Cisco. “By collaborating with NetApp to extend Cisco Secure AI Factory with NVIDIA to our validated FlexPod solution, we’re helping customers address AI‑specific risks such as data exposure, governance gaps, and compliance challenges while simplifying how AI infrastructure is deployed and operated.”

"Enterprises are sitting on vast amounts of data, but without the discovery, governance and preparation built into the infrastructure itself, enterprises will struggle to power production AI,” said Jason Hardy, vice president, Storage Technologies at NVIDIA. “NetApp AI Data Engine, co-engineered on the NVIDIA AI Data Platform and validated with the Cisco Secure AI Factory with NVIDIA, gives organizations the secure, AI-ready data foundation to deploy AI factories on FlexPod infrastructure at scale."

"The new AI capabilities in FlexPod expand our ability to help customers navigate the AI era with confidence," said Brian Bartell, Practice Manager, Compute & Storage at WWT. "Through our long-standing partnerships with NetApp and Cisco, the introduction of NetApp's AI Data Engine, and the ability to validate these architectures hands-on in WWT's AI Proving Ground, we can compress the time from concept to execution, giving our customers a pre-tested, industry-leading foundation to move at the speed of the market and unlock the power of their data."

To learn more about NetApp's partnership with Cisco, visit the NetApp booth #7414 at Cisco Live!, May 31-June 4 at Mandalay Bay in Las Vegas.

Additional Resources

About NetApp

For more than three decades, NetApp has helped the world’s leading organizations navigate change – from the rise of enterprise storage to the intelligent era defined by data and AI. Today, NetApp is the Intelligent Data Infrastructure company, helping customers turn data into a catalyst for innovation, resilience, and growth.

At the heart of that infrastructure is the NetApp data platform – the unified, enterprise-grade, intelligent foundation that connects, protects, and activates data across every cloud, workload, and environment. Built on the proven power of NetApp ONTAP, our leading data management software and OS, and enhanced by automation through the AI Data Engine and AFX, it delivers observability, resilience, and intelligence at scale.

Disaggregated by design, the NetApp data platform separates storage, services, and control so enterprises can modernize faster, scale efficiently, and innovate without lock-in. As the only enterprise storage platform natively embedded in the world’s largest clouds, it gives organizations the freedom to run any workload anywhere with consistent performance, governance, and protection.

With NetApp, data is always ready – ready to defend against threats, ready to power AI, and ready to drive the next breakthrough. That’s why the world’s most forward-thinking enterprises trust NetApp to turn intelligence into advantage.

Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at http://www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word ‘partner’ does not imply a partnership relationship between Cisco and any other company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260603146499/en/

Contacts

Media Contact:
Kenya Hayes
NetApp
kenya.hayes@netapp.com

Taylor Hassman
Cisco
thassman@cisco.com

Investor Contact:
Kris Newton
NetApp
kris.newton@netapp.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press Release

Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A

Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press Release

Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye